Articles with keyword non-small cell lung cancer

EVOLUTION OF TYROSINE KINASE RESISTANCE IN EGFR MUTATED NON-SMALL CELL LUNG CANCER (F.V. Moiseenko)

non-small cell lung cancer, epidermal growth factor receptor, targeted therapy, resistance.

The role of liquid biopsy in the choice of tactics For the treatment of non-small cell lung cancer (K.K. Laktionov, A.M. Kazakov, K.A. Sarantseva, E.V. Reutova, A.L. Arzumanyan, N.M. Moskalyuk)

non-small cell lung cancer, fluid biopsy, mutation profile, minimal residual disease

NEW IN DRUG TREATMENT OF SOLID TUMORS (V.V. Petkau, I.S. Bulavina)

non-small cell lung cancer, breast cancer, Osimertinib, Alectinib, Ribociclib, Abemaciclib, Neratinib, Olaparib.

EVOLUTION OF DRUG THERAPY FOR LUNG CANCER WITH EGFR INHIBITORS: NEW ASPECTS (M.L. Stepanova, L.V. Khalicova, A.S. Zhabina, F.V. Moiseenko)

non-small cell lung cancer, epidermal growth factor receptor, targeted therapy, osimertinib.

Clinical experience of afatinib application In non-cell lung cancer of lung. Ii line of therapy (L.M. Kogoniya, E.V. Markarova, G.A. Stashuk, V.E. Shikina)

lung cancer, adenocarcinoma, non-small cell lung cancer, EGFR mutation, chemotherapy, targeted therapy, efficacy, elderly, side effects